The Malaria Funding Request

All funding requests submitted to the Global Fund on the 23rd May 2017 are tailored applications, which means that they primarily describe those interventions that are subject to change while maintaining a large number of existing interventions. The malaria funding request aims at reducing:

  • Malaria parasite prevalence among children aged
    6 - 59 months from 20.4% in 2016 to 14% by 2020;
  • Inpatient malaria deaths from 4.4/1000 persons in 2016
    to 2/1000 persons by 2020

and focuses on the following: 

  1. Malaria diagnostic test rate (Microscopy & RDT) will be improved from 77% in 2016 to 100% by 2020. 84% of the case management funds will be spent for commodities as RDTs and ACTs.
  2. Private sector copayments to ensure availability of low cost ACTs in private pharmacies will be limited to rural areas only and be eventually weaned off.
  3. Bed net mass campaign distribution will be changed from the current rolling (30 months) to one consolidated campaign (6-8 months) and be limited to regions and districts that are not covered by IRS.
  4. IRS will be continued in 23 districts, of which 12 are supported by the Global Fund, seven by PMI and four by the NGenIRS project.
  5. A significant scale up is planned for the coverage of pregnant women through IPTp. The proportion of pregnant women attending antenatal clinics who receive three or more doses will increase from 36.4% (2016) to 61% by 2020.
  6. SMC will be maintained in Upper East and Upper West Regions. If additional funds become available, it is proposed to expand coverage to Northern Region (Prioritized Above Allocation Request)